IperionX Limited Sponsored ADR (NASDAQ:IPX - Get Free Report) CEO Anastasios Arima purchased 110,000 shares of the firm's stock in a transaction dated Tuesday, April 28th. The shares were bought at an average price of $4.49 per share, with a total value of $493,900.00. Following the purchase, the chief executive officer owned 12,316,782 shares in the company, valued at $55,302,351.18. The trade was a 0.90% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.
IperionX Trading Up 15.2%
Shares of IPX stock opened at $33.48 on Friday. The company has a 50 day moving average of $34.31 and a 200-day moving average of $39.08. The company has a debt-to-equity ratio of 0.03, a quick ratio of 4.00 and a current ratio of 4.03. IperionX Limited Sponsored ADR has a 12-month low of $19.43 and a 12-month high of $61.45.
IperionX (NASDAQ:IPX - Get Free Report) last issued its quarterly earnings results on Saturday, January 31st. The company reported ($0.50) earnings per share (EPS) for the quarter. As a group, analysts predict that IperionX Limited Sponsored ADR will post -0.12 earnings per share for the current fiscal year.
IperionX News Roundup
Here are the key news stories impacting IperionX this week:
- Positive Sentiment: Senior insiders bought material stock positions — Chairman Todd Hannigan disclosed purchases (220,000 shares at ~$4.48 on Apr 28 and 260,000 shares at ~$4.20 on Apr 29) and CEO Anastasios Arima bought 110,000 shares (~$4.49 on Apr 28). Management’s sizable, repeated buys (combined purchases >$2m) signal confidence in the company’s outlook and are the most likely near-term driver of the stock’s uptick. Chairman SEC Filing CEO SEC Filing
- Positive Sentiment: Analyst coverage remains bullish overall: multiple firms maintain Buy/Outperform ratings and the consensus target (per MarketBeat) sits well above current trade, which can amplify buying when insider signals appear. MarketBeat Analyst Summary
- Neutral Sentiment: IperionX is shifting its Stony Creek operations toward 24/7 output, a move that could lift future production and revenues but increases near-term execution focus. Investors will watch operational ramp metrics for proof of delivery. 24/7 Output Article
- Neutral Sentiment: Coverage and opinion pieces (e.g., “Is it too late to consider IperionX”) are circulating — these can attract retail momentum but don’t change fundamentals by themselves. Valuation/Opinion Article
- Negative Sentiment: Risks remain: public filings and coverage note negative EPS and analyst forecasts for the fiscal year, and some articles flag rising execution and funding risk as the company scales — these are reasons for continued volatility and could cap upside if operational targets or financing do not progress. Execution & Funding Risk Article MarketBeat Financials
Institutional Investors Weigh In On IperionX
A number of hedge funds and other institutional investors have recently bought and sold shares of IPX. Van ECK Associates Corp bought a new stake in IperionX during the 3rd quarter valued at $40,997,000. Millennium Management LLC bought a new stake in IperionX during the 4th quarter valued at $4,249,000. Jane Street Group LLC raised its holdings in IperionX by 62.5% during the 4th quarter. Jane Street Group LLC now owns 129,020 shares of the company's stock valued at $4,669,000 after acquiring an additional 49,645 shares during the period. Private Advisor Group LLC raised its holdings in IperionX by 69.9% during the 1st quarter. Private Advisor Group LLC now owns 63,111 shares of the company's stock valued at $1,643,000 after acquiring an additional 25,964 shares during the period. Finally, Bank of America Corp DE raised its holdings in IperionX by 69.0% during the 2nd quarter. Bank of America Corp DE now owns 35,441 shares of the company's stock valued at $1,116,000 after acquiring an additional 14,467 shares during the period. Institutional investors own 2.76% of the company's stock.
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on IPX shares. Alliance Global Partners reiterated a "buy" rating on shares of IperionX in a research note on Tuesday. B. Riley Financial cut their price target on IperionX from $58.00 to $52.00 and set a "buy" rating for the company in a research note on Friday, March 13th. BTIG Research started coverage on IperionX in a research note on Friday, March 27th. They set a "buy" rating and a $40.00 price target for the company. William Blair started coverage on IperionX in a research note on Tuesday, January 13th. They set an "outperform" rating for the company. Finally, Roth Mkm reiterated a "buy" rating and set a $74.00 price target on shares of IperionX in a research note on Tuesday, January 20th. Five equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $55.33.
View Our Latest Research Report on IperionX
About IperionX
(
Get Free Report)
IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of high‐purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.
At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
